UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:May 05,
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Cassava Sciences Charts.
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Cassava Sciences Charts.

Cassava Sciences Inc News

Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQ
Wednesday 1 May 2024 (1 week ago) • GlobeNewswire Inc.
Redemption Date Announced for Warrants
Monday 15 April 2024 (3 weeks ago) • GlobeNewswire Inc.
Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
Tuesday 26 March 2024 (1 month ago) • GlobeNewswire Inc.
Cassava Sciences Announces Virtual Presentation at the AD/PD™ 2024 International Conference
Tuesday 5 March 2024 (2 months ago) • GlobeNewswire Inc.
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)
Cassava Sciences Reports Full-year 2023 Financial Results and Corporate Updates
Thursday 29 February 2024 (2 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Thursday 8 February 2024 (3 months ago) • Edgar (US Regulatory)
No Decline in Cognition Scores in Patients with Mild Alzheimer's Disease Who Received Simufilam Continuously For 24 Months
Thursday 8 February 2024 (3 months ago) • GlobeNewswire Inc.
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Friday 2 February 2024 (3 months ago) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Saturday 27 January 2024 (3 months ago) • Edgar (US Regulatory)
Cassava Sciences Completes Dividend Distribution of Warrants to Shareholders
Saturday 6 January 2024 (4 months ago) • GlobeNewswire Inc.

More Cassava Sciences Inc News Articles